First patient treated with Elekta's new non-invasive radiotherapy system
for brain tumours
Stockholm, Sweden & Marseille, France. The Leksell Gamma Knife Perfexion
from Swedish company Elekta (STO:EKTAB), a new system for stereotactic
radiosurgery on brain tumours, has for the first time been used clinically
to treat patients at Hôpital de la Timone
(University Hospital La Timone) in Marseille, France.
radiosurgery is a non-invasive method for treating brain disorders that
delivers a single, high dose of irradiation to a small and precisely located
intra-cranial volume through the intact skull.
The Leksell Gamma Knife Perfexion has been designed for unlimited cranial
reach and ease of use and comfort for both patients and staff. It provides a
radiosurgical platform for further refinement and expansion of procedures in
the brain, cervical spine and head & neck regions.
University Hospital La
Timone is first in the world to have one nstalled and in clinical use. On
July 10, three patients were successfully treated.
"We are very proud to
be the first clinic in the world to be able to provide stereotactic
radiosurgery with Leksell Gamma Knife Perfexion, a highly sophisticated
system allowing us to treat more patients. Both patients and staff will
benefit from the smart design that will rationalize our work procedures,
giving us more time to focus on our patients", comments Professor Jean
University Hospital La Timone is an internationally well recognized
clinic and a centre of excellence in radiosurgery. Professor Jean Regis has
also participated with very valuable expert advice in the development
process of Leksell Gamma Knife Perfexion.
"I am very pleased to see that
four years of research and development pays off and comes to the benefit of
patients, first here in France but also in the future throughout the world
with more installation of this truly innovative system", says Tomas Puusepp,
President and CEO of Elekta.
Leksell Gamma Knife Perfexion is subject to
regulatory clearance in North America.